KRYS
Krystal Biotech, Inc. · Healthcare
Director Dino A Rossi sold $3.3M of Krystal Biotech, Inc.
Sold$3,329,972
$83.25Price
40,000Shares
−32%Stake
What KRYS did after the filing
- The stock from Thu, Mar 2 close, $81.82
- +5.6%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Apr 14 close.
Traded Wed, Mar 1. Filed Thu, Mar 2, 12:05 PM ET, during the session. Returns use the Mar 2 close and the Apr 14 close. Not investment advice.